4//SEC Filing
Gutwerg Ori 4
Accession 0001846478-23-000002
CIK 0001023024other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:22 PM ET
Size
10.2 KB
Accession
0001846478-23-000002
Insider Transaction Report
Form 4
Gutwerg Ori
SVP, GENERICS
Transactions
- Exercise/Conversion
Common Stock
2023-08-23$31.49/sh+13,502$425,178→ 76,476 total - Sale
Common Stock
2023-08-23$62.39/sh−13,502$842,390→ 62,974 total - Exercise/Conversion
Stock Option (right to buy)
2023-08-23$31.49/sh−13,502$425,178→ 13,504 totalExercise: $31.49Exp: 2031-02-15→ Common Stock (13,502 underlying) - Sale
Common Stock
2023-08-23$62.39/sh−2,059$128,461→ 60,915 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.31 to $62.68, inclusive.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.32 to $62.50, inclusive.
- [F3]25% of the total options vested on each of February 15, 2022 and February 15, 2023. 25% of the total options will vest on each of February 15, 2024 and February 15, 2025.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001846478
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 4:22 PM ET
- Size
- 10.2 KB